Market closed · Next open: Monday 9:30 AM ET
Last update: Oct 30, 2026, 6:17 PM ET
IDEXX Laboratories, Inc.
$551.21▼ 4.30% today
Market Closed

Why IDEXX Laboratories, Inc. (IDXX) stock moved

Updated Oct 31, 2026

IDEXX Laboratories, Inc. (IDXX) shares fell 4.3% to $551.21 as of October 31, 2026, a moderate decline from the prior close of $575.98. BestStocks flagged the session as a major change for IDXX. The move is tied to price move down. Below, we break down what changed for IDXX, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

IDXX fell 4.3% to $551.21

IDXX fell 4.3% in its latest session, moving from $575.98 to $551.21.

Material / EarningsMedium confidence
Rel. volume
2.0×
Above Avg
Vs peers
—
No comparable peers
Market cap
$43.4B
NASDAQ Global Select
Analyst target
$692
+25.6% vs price
Price chart
Sep 30 – Oct 30
EVNNNNNNNNE$506$541$577Sep 30Oct 8Oct 15Oct 23Oct 30
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for IDEXX Laboratories, Inc. investors

For IDEXX Laboratories, Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Positive price momentum. Weighing against that: Material negative event; Negative session, down 4.3%. Wall Street's consensus price target sits at $692.33, implying +25.6% upside from $551.21. BestStocks rates the overall signal quality medium (63/100). With earnings roughly 2 days out, the next report is the most likely near-term test of the move.

IDXX price reaction

IDXX last traded at $551.21, down $24.77 (-4.30%) from the previous close of $575.98. The session traded on 2.0× average volume (above avg), so the move carried above-average conviction. Over the past month the stock has ranged between $506.67 and $575.98, and it currently sits about 64% of the way up that band.

Bullish and bearish analyst opinions on IDEXX Laboratories, Inc. (IDXX)

The consensus analyst price target on IDEXX Laboratories, Inc. (IDXX) is $692.33, 25.6% above the recent $551.21. Over the past 90 days analysts logged 0 upgrades, 5 maintains, and 0 downgrades. Here is how the bullish and bearish cases on IDXX line up.

The bullish case

  • Wall Street's consensus price target of $692.33 implies +25.6% upside from $551.21.
  • The Street's most bullish target is $740.00 (+34.3%).
  • Positive price momentum.

The bearish case

  • Material negative event.
  • Negative session, down 4.3%.
Bull vs bear balanceBearish Shift
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Oct 31, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $692+25.6%
= 5 maintains
UBS maintained Neutral · 2026-10-27
SEC filings watch
10-Q2026-08-04
Quarterly financial results
medium
8-K2026-08-04
Material event — review for impact
high
Peer context
IDXX-4.3%

Previous notable changes for IDXX

News2026-10-28+0.3%
IDXX reports Q3 2026 earnings with Wall Street analyzing performance against revenue and profitability estimates.
News2026-10-27-1.6%
Citizens Financial Group increased IDXX stake by 51.1% to 3,400 shares in Q3.
News2026-10-26+1.8%
IDXX scheduled to report earnings next week with Wall Street expecting earnings growth.
News2026-10-23-1.1%
IDEXX enters Q3 earnings reporting period with expected revenue and EPS growth driven by CAG Diagnostics, testing volumes, and software.
Upcoming catalysts & outlook
Next earnings
2026-11-02 (est.)
in 2 days
10-Q Filing (est.)
2026-11-03
Medium impact
Thesis shift
Bearish Shift
bearish signal
Risk level
Low
from change events

Frequently asked questions about IDXX

Why did IDEXX Laboratories, Inc. (IDXX) stock move?

IDXX fell 4.3% to $551.21. No single company-specific catalyst was confirmed during the move window, and it looks technical.

How much did IDXX stock fall?

IDXX lost 4.30% ($24.77) versus the prior close of $575.98, last trading at $551.21 on 2.0× average volume.

When is IDEXX Laboratories, Inc.'s next earnings date?

IDXX's next earnings report is estimated for 2026-11-02 — about 2 days away.

What is the analyst price target for IDXX?

The consensus analyst price target for IDXX is $692.33, about 25.6% above the current $551.21. Over the past 90 days, analysts recorded 0 upgrades, 5 maintains, and 0 downgrades.

How BestStocks tracks IDXX

This page is generated automatically by BestStocks' change-detection system after price move down was detected and verified against independent data sources. It draws on 20 tracked change events for IDXX, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of October 31, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataCompany news feedsSEC EDGAR filingsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.